These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 10944550)

  • 1. A family of drug transporters: the multidrug resistance-associated proteins.
    Borst P; Evers R; Kool M; Wijnholds J
    J Natl Cancer Inst; 2000 Aug; 92(16):1295-302. PubMed ID: 10944550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.
    Zhou SF; Wang LL; Di YM; Xue CC; Duan W; Li CG; Li Y
    Curr Med Chem; 2008; 15(20):1981-2039. PubMed ID: 18691054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy.
    Keppler D
    Handb Exp Pharmacol; 2011; (201):299-323. PubMed ID: 21103974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance associated proteins in multidrug resistance.
    Sodani K; Patel A; Kathawala RJ; Chen ZS
    Chin J Cancer; 2012 Feb; 31(2):58-72. PubMed ID: 22098952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?
    Borst P; Kool M; Evers R
    Semin Cancer Biol; 1997 Jun; 8(3):205-13. PubMed ID: 9441949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate.
    Homolya L; Váradi A; Sarkadi B
    Biofactors; 2003; 17(1-4):103-14. PubMed ID: 12897433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulators of multidrug resistance associated proteins in the management of anticancer and antimicrobial drug resistance and the treatment of inflammatory diseases.
    Yang AK; Zhou ZW; Wei MQ; Liu JP; Zhou SF
    Curr Top Med Chem; 2010; 10(17):1732-56. PubMed ID: 20645920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of amphipathic anions by human multidrug resistance protein 3.
    Zeng H; Liu G; Rea PA; Kruh GD
    Cancer Res; 2000 Sep; 60(17):4779-84. PubMed ID: 10987286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic secretion of conjugated drugs and endogenous substances.
    Keppler D; König J
    Semin Liver Dis; 2000; 20(3):265-72. PubMed ID: 11076395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance-associated proteins and implications in drug development.
    Liu YH; Di YM; Zhou ZW; Mo SL; Zhou SF
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):115-20. PubMed ID: 19566819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane.
    König J; Rost D; Cui Y; Keppler D
    Hepatology; 1999 Apr; 29(4):1156-63. PubMed ID: 10094960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats.
    van Vliet EA; Redeker S; Aronica E; Edelbroek PM; Gorter JA
    Epilepsia; 2005 Oct; 46(10):1569-80. PubMed ID: 16190927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance caused by multidrug resistance-associated proteins.
    Wijnholds J
    Novartis Found Symp; 2002; 243():69-79; discussion 80-2, 180-5. PubMed ID: 11990783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs.
    Yu XQ; Xue CC; Wang G; Zhou SF
    Curr Drug Metab; 2007 Dec; 8(8):787-802. PubMed ID: 18220559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.
    König J; Nies AT; Cui Y; Leier I; Keppler D
    Biochim Biophys Acta; 1999 Dec; 1461(2):377-94. PubMed ID: 10581368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of triple-transfected cells [organic anion-transporting polypeptide (OATP) 1B1/multidrug resistance-associated protein (MRP) 2/MRP3 and OATP1B1/MRP2/MRP4] for analysis of the sinusoidal function of MRP3 and MRP4.
    Hirouchi M; Kusuhara H; Onuki R; Ogilvie BW; Parkinson A; Sugiyama Y
    Drug Metab Dispos; 2009 Oct; 37(10):2103-11. PubMed ID: 19628752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.
    Wortelboer HM; Usta M; van der Velde AE; Boersma MG; Spenkelink B; van Zanden JJ; Rietjens IM; van Bladeren PJ; Cnubben NH
    Chem Res Toxicol; 2003 Dec; 16(12):1642-51. PubMed ID: 14680379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
    Assaraf YG
    Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited modulation of the transport activity of the human multidrug resistance proteins MRP1, MRP2 and MRP3 by nicotine glucuronide metabolites.
    Létourneau IJ; Bowers RJ; Deeley RG; Cole SP
    Toxicol Lett; 2005 May; 157(1):9-19. PubMed ID: 15795089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.